专利详细信息
专利号 | HRP20121005T1 |
专利标题 | DOSAGE FORM CONTAINING PANTOPRAZOLE AS ACTIVE INGREDIENT |
专利权人 | NYCOMED GMBH [DE]; |
发明人 | DIETRICH RANGO [DE]; ANSTETT-KLEIN ISABEL [DE]; SCHILLER MARC [DE]; NEY HARTMUT [DE]; HARTMANN MANFRED [DE]; SCHAEFER-PREUSS SABINE [DE]; |
申请号 | HRP20121005T |
申请日 | 2012/12/6 |
公开日 | 2013/1/31 |
优先权号 |
EP20030010328 20030508 EP20040001754 20040128 |
IPC | A61K00314439; A61K000916; A61K000920; A61K000926; A61K000928; A61K000932; A61K000950; A61K003144; A61K004732; |
专利类型 | |
法律状态查询 | 查看法律状态 |
专利号 | 专利名称 | 专利权人 | 优先权号 |
---|---|---|---|
EP2316454A1 | Dosage form containing pantoprazole as active ingredient | NYCOMED GMBH [DE]; | EP20040741525 EP20030010328 EP20040001754 EP20100175417 |
CN101524336A | Dosage forms for oral administration of magnesium salt of pantoprazole | NICOMEDE CO LTD [DE]; | EP20030010328 |
CA2563162A1 | DOSAGE FORM CONTAINING PANTOPRAZOLE AS ACTIVE INGREDIENT | ALTANA PHARMA AG [DE]; | EP20030010328 EP20040001754 CA20042489140 |
AU2010200905A1 | Dosage form containing pantoprazole as active ingredient | NYCOMED GMBH; | AU20040237363 AU20100200905 WO2004EP50729 EP20030010328 EP20040001754 |
US2009208571A1 | Dosage form containing pantoprazole as active ingredient | NYCOMED GMBH [DE]; | US20090385280 EP20030010328 EP20040001754 US20050555238 WO2004EP50729 |
HK1090546A1 | DOSAGE FORM CONTAINING PANTOPRAZOLE AS ACTIVE INGREDIENT | NYCOMED GMBH [DE]; | WO2004EP50729 EP20030010328 EP20040001754 |
US2006240100A1 | Dosage form containing pantoprazole as active ingredient | ALTANA PHARMA AG [DE]; | EP20030010328 EP20040001754 WO2004EP50729 |
KR20060010774A | DOSAGE FORM CONTAINING PANTOPRAZOLE AS ACTIVE INGREDIENT | ALTANA PHARMA AG [DE]; | EP20030010328 EP20040001754 |
NZ543181A | Dosage form containing magnesium salt of pantoprazole as active ingredient | NYCOMED GMBH; | EP20030010328 EP20040001754 WO2004EP50729 |
WO2004098594A2 | DOSAGE FORM CONTAINING PANTOPRAZOLE AS ACTIVE INGREDIENT | ALTANA PHARMA AG [DE];ANSTETT ISABEL [DE];DIETRICH RANGO [DE];NEY HARTMUT [DE];SCHILLER MARC [DE];SCHAEFER-PREUSS SABINE [DE];HARTMANN MANFRED [DE]; | EP20030010328 EP20040001754 |
EP1624869A2 | DOSAGE FORM CONTAINING PANTOPRAZOLE AS ACTIVE INGREDIENT | ALTANA PHARMA AG [DE]; | WO2004EP50729 EP20030010328 EP20040001754 EP20040741525 |
CN1784227A | Dosage form containing pantoprazole as active ingredient | ALTANA PHARMA AG [DE]; | EP20030010328 |
CA2489140A1 | DOSAGE FORM CONTAINING PANTOPRAZOLE AS ACTIVE INGREDIENT | ALTANA PHARMA AG [DE]; | EP20030010328 EP20040001754 WO2004EP50729 |
AU2004237363A1 | Dosage form containing pantoprazole as active ingredient | ALTANA PHARMA AG; | EP20030010328 EP20040001754 WO2004EP50729 |
EA016824B1 | DOSAGE FORM CONTAINING PANTOPRAZOLE AS ACTIVE INGREDIENT | NYCOMED GMBH [DE]; | EP20030010328 EP20040001754 WO2004EP50729 |
没有相关的数据
暂无附图
注:除CN专利外,本系统默认提供的所有其他中文标题和摘要来自机器翻译。